Exact Mass: 230.1419

Exact Mass Matches: 230.1419

Found 54 metabolites which its exact mass value is equals to given mass value 230.1419, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Camoensine

Oprea1_574945

C14H18N2O (230.1419)

Ibudilast

2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one

C14H18N2O (230.1419)

Ibudilast is an anti-inflammatory and neuroprotective oral agent which shows an excellent safety profile at 60 mg/day and provides significantly prolonged time-to-first relapse and attenuated brain volume shrinkage in patients with relapsing-remitting (RR) and/or secondary progressive (SP) multiple sclerosis (MS). Ibudilast is currently in development in the U.S. (codes: AV-411 or MN-166), but is approved for use as an antiinflammatory in Japan. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Propyphenazone

1,5-dimethyl-2-phenyl-4-(propan-2-yl)-2,3-dihydro-1H-pyrazol-3-one

C14H18N2O (230.1419)

N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BB - Pyrazolones C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

5,6-Dehydroalbine

C14H18N2O (230.1419)

11alpha-Allylcytisine

C14H18N2O (230.1419)

Propyphenazone

4-Isopropylantipyrine

C14H18N2O (230.1419)

1,2-Dimethyl-6-methoxy-1,2,3,4-tetrahydro-beta-carboline

C14H18N2O (230.1419)

Alkaloid PA-I

C14H18N2O (230.1419)

1-propyl-2,3,4,9-tetrahydro-1H-beta-carbolin-6-ol|1-Propyl-6-hydroxy-1,2,3,4-tetrahydro-2-carboline|1-Propyl-6-hydroxyl-1,2,3,4-tetrahydro-beta-carboline|schobericine|schobicine

C14H18N2O (230.1419)

4-allyl-1,2,5,6,11,11a-hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-10-one|Dehydro-albin|Dehydroalbin

C14H18N2O (230.1419)

Propyphenazon

Propyphenazone

C14H18N2O (230.1419)

N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BB - Pyrazolones C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; INTERNAL_ID 4071 D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

Tabernanthalog

C14H18N2O (230.1419)

Ketas

2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one

C14H18N2O (230.1419)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

BRL 54443 is a potent 5-HT1E/1F receptor agonist (Ki values are 1.1 nM and 0.7 nM respectively); displays > 30-fold selectivity over other 5-HT and dopamine receptors[1].

(1s,9r,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,5-dien-4-one

C14H18N2O (230.1419)

(1s,9s,10r)-10-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C14H18N2O (230.1419)

7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

C14H18N2O (230.1419)

12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,5-dien-4-one

C14H18N2O (230.1419)

(1r,9r,10r)-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

C14H18N2O (230.1419)

(1s,9s,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,5-dien-4-one

C14H18N2O (230.1419)

(1s,9s,10s)-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

C14H18N2O (230.1419)

10-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C14H18N2O (230.1419)